References
- Hamilton-Miller JM. Immunopharmacology of antibiotics: direct and indirect immunomodulation of defence mechanisms. J Chemother 2001; 13 (2): 107–11.
- Parnham MJ Immunomodulatory effects of antimicro-bials in the therapy of respiratory tract infections Curr Opin Infect Dis 2005; 18 (2): 125-31.
- Takahashi HK, Iwagaki H, Xue D, et al. Effect of ciprofloxacin-induced prostaglandin E2 on interleukin-18-treat-ed monocytes. Antimicrob Agents Chemother 2005; 49 (8): 3228–33.
- Katsuno G, Takahashi HK, Iwagaki H, et al. The immunosuppressive effects of ciprofloxacin during humanmixed lymphocyte reaction. Clin Immunol 2006; 119 (1): 110-9. Epub 2006 Feb 2.
- Nicoletti F, Meroni PL, Bendtzen K. Fusidic acid and insulin-dependent diabetes mellitus. Autoimmunity 1996; 24 (3): 187–97.
- Dabrowski MP, Stankiewicz W. Desirable and undesir-able immunotropic effects of antibiotics: immunomodulating properties of cefaclor. J Chemother 2001; 13 (6): 615–20.
- Periti P. Immunopharmacology of oral betalactams. J Chemother 1998; 10 (2): 91–6.
- Scheffer J, Konig W. Cephalosporins and inflammatory host reactions. Respiration 1993;60 Suppl 1: 25–31.
- Scheffer J, Knoller J, Cullmann W, Konig W. Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes. J Antimicrob Chemother 1992; 30 (1): 57-66.1°
- Stubner G. The effect of sub-inhibitory concentrations of cefaclor, erythromycin and doxycycline on phagocytosis and intracellular killing of E. coli by human neutrophil granulo-cytes. Arzneimittelforschung 1986; 36 (11): 1702–4.
- McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Thl/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002; 23 (9): 450–5.
- Aoki N, Xing Z. Use of cytokines in infection. Expert Opin Emerg Drugs 2004; 9 (2): 223–36.
- Kaufmann SH, Schaible UE. Antigen presentation and recognition in bacterial infections. Curr Opin Immunol 2005; 17 (1): 79–87.
- Nicoletti F, Mancuso G, Cusumano V, Di Marco R, Zaccone P, Bendtzen K, Teti G. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur J Immunol 1997; 27 (6): 1580–3.
- Ferrante A. Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors. Immunol Ser 1992; 57: 417–36.